ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2110

Association of Systemic Lupus Erythematosus (SLE) Genetic Susceptibility Loci with Lupus Nephritis in Children and Adults with SLE

Declan Webber1, Jingjing Cao2, Daniela Dominguez3, Dafna D Gladman4, Deborah M. Levy5, Lawrence Ng3, Andrew Paterson3, Zahi Touma6, Murray Urowitz7, Joan E. Wither8, Earl Silverman5 and Linda Hiraki9, 1Department of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Genetics & Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 5Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 6University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 7Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 8Krembil Research Institute, University Health Network, Toronto, ON, Canada, 9Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Genetic architecture, Lupus nephritis, Pediatric rheumatology and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex, chronic, autoimmune disease. Genome-wide association studies (GWAS) have identified multiple risk SNPs in HLA and non-HLA gene regions. There is evidence that genetics are also important in lupus nephritis (LN) risk. LN is one of the most common and severe manifestations of SLE. The purpose of this study was to determine the association of known SLE risk SNPs with LN in both childhood-onset (cSLE) and adult-onset SLE (aSLE) populations.

Methods: The study population included two tertiary care SLE cohorts; one with cSLE and the other with aSLE. Participants met American College of Rheumatology (ACR) and/or Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for SLE, with prospectively collected clinical and laboratory data. Participants were genotyped on the Illumina MEGA or Omni1 arrays. Principal components were calculated in reference to the 1000 genomes project, and ancestry was genetically inferred. Ungenotyped SNPs were imputed. HLA alleles were imputed in Europeans only. HLA and non-HLA additive SLE weighted genetic risk scores (GRSs) were computed using published SLE GWAS weights. LN was confirmed by renal biopsy as defined by the WHO or the International Society of Nephrology/Renal Pathology Society or diagnosed with renal casts, hematuria, proteinuria, and/or pyuria on two consecutive urinalyses. HLA and non-HLA GRSs were regressed individually and jointly, against LN risk in logistic regression models stratified by cSLE/aSLE cohort and ancestry, adjusted for sex, age of SLE diagnosis, and duration of follow-up. Effect estimates from stratified analyses were meta-analyzed using inverse-variance weighted fixed effects models.

Results: The cohorts included 421 with cSLE and 878 with aSLE. The mean age of diagnosis of patients with cSLE was 12.9 years (SD=3.2), 82% were female and 41% had LN. Among the aSLE patients, the mean age of diagnosis was 30.2 years (SD=13.1), 89% were female and 39% had LN. Genotyping and imputation resulted in 11.5M SNPs with minor allele frequency ≥0.01 and imputation quality ≥0.9. Meta-analyses demonstrated that increasing non-HLA GRS was significantly associated with increased LN risk (OR = 1.27; 95% CI: 1.11, 1.45, p = 0.0005). The strongest effect was observed among Europeans with cSLE (OR = 1.60; 95% CI: 1.08, 2.35, p = 0.018), whereas in those with aSLE the association was positive but not significant (OR=1.12; 95% CI: 0.91, 1.37, p = 0.291). HLA-GRS was not significantly associated with increased LN risk in meta-analysis of all Europeans, yet was significant in Europeans with cSLE (OR = 2.14; 95% CI: 1.00, 4.59; p = 0.0499). This association was insignificant in Europeans with aSLE (OR = 1.03; 95 % CI: 0.56, 1.90; p = 0.923).

Conclusion: We found a significant association between non-HLA SLE genetic risk SNPs and LN in our cohort of children and adults with SLE. We found that the effects were strongest among the childhood-onset SLE patients of European ancestry. The HLA risk alleles were also associated with LN risk, but did not reach statistical significance. Futures studies will include additional SLE cohorts.


Disclosure: D. Webber, None; J. Cao, None; D. Dominguez, None; D. D. Gladman, None; D. M. Levy, None; L. Ng, None; A. Paterson, None; Z. Touma, None; M. Urowitz, None; J. E. Wither, None; E. Silverman, None; L. Hiraki, None.

To cite this abstract in AMA style:

Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, Paterson A, Touma Z, Urowitz M, Wither JE, Silverman E, Hiraki L. Association of Systemic Lupus Erythematosus (SLE) Genetic Susceptibility Loci with Lupus Nephritis in Children and Adults with SLE [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-of-systemic-lupus-erythematosus-sle-genetic-susceptibility-loci-with-lupus-nephritis-in-children-and-adults-with-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-systemic-lupus-erythematosus-sle-genetic-susceptibility-loci-with-lupus-nephritis-in-children-and-adults-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology